Skip To Main Content
Le contenu de ce site web est exclusivement réservé aux professionnels de santé en Belgique et au Luxembourg.
Campus
  • Aires thérapeutiques
  • Ressources
Campus
  • Aires thérapeutiques
  • Ressources
View Full Results

Articles

Sort by

Filtres

Réinitialiser
  • Aires thérapeutiques

SINUS-24/SINUS-52 Demonstrated Reduced Need for Surgery and Oral Corticosteroids — Dupilumab Real-World Data Reinforces with 100% Reduction in the First Year of Treatment in Patients with Severe Uncontrolled CRSwNP

This Italian monocentric study (De Corso et al., 2022) evaluated the real-life effectiveness of dupilumab over the first year of treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (N=57).2 The results from this real-life observational study reinforces the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and both the study design and results are consistent with the approved SmPC.1,2,3

Explorer

Unstoppable commitment to ASCVD care for over 10 years

Explorer

L'importance de la fonction pulmonaire dans l’asthme sévère – Perspective clinique

Explorer

Cycle of Recurrence: A Challenge in CRSwNP Patients

Explorer

Chronic Rhinosinusitis with Nasal Polyps: The Interplay of Type 2 Inflammation and Smell Loss

Explorer

Chronic Rhinosinusitis with Nasal Polyps: More Than Just Nasal Obstruction

Explorer

PCSK9 inhibitor treatment and outcomes

Explorer

Loss of Smell in CRSwNP

Loss of sense of smell is a common symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), but its impact is often underestimated. Learn how olfactory dysfunction affects patient’s quality of life and explore the underlying mechanisms driving smell loss in CRSwNP.

Explorer

Les Biomarqueurs dans l'Asthme : Intervention Précoce avec la Médecine de Précision

Explorer

Beyfortus®▼ (nirsevimab): efficacité et impact sur la santé publique dans le monde réel

Explorer

Insulin-Related Weight Gain in Type 2 Diabetes: Practical Guidance

Explorer

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

Explorer